Inventor
GUEHRING HANS
DE17 patents
⚠️ This page may combine multiple inventors who share the name “GUEHRING HANS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK PATENT GMBH
14 patentsUS11513128B2Nov 29, 2022
Metabolic biomarkers for predicting responsiveness to FGF-18 compound
MERCK PATENT GMBH5 citations71
US11467169B2Oct 11, 2022
Inflammatory biomarkers for predicting responsiveness to FGF-18 compound
MERCK PATENT GMBH4 citations71
US11261260B2Mar 1, 2022
ADAMTS binding immunoglobulins
MERCK PATENT GMBH4 citations71
US10086112B2Oct 2, 2018
Implant comprising FGF-18
MERCK PATENT GMBH4 citations71
US9889179B2Feb 13, 2018
FGF-18 compound dosing regimen
MERCK PATENT GMBH4 citations71
US9724388B2Aug 8, 2017
FGF-18 compound dosing regimen
MERCK PATENT GMBH4 citations71
US12129308B2Oct 29, 2024
MMP13 binding immunoglobulins
MERCK PATENT GMBH2 citations70
US11813307B2Nov 14, 2023
Polypeptides binding ADAMTS5, MMP13 and aggrecan
MERCK PATENT GMBH2 citations70
US12332250B2Jun 17, 2025
Inflammatory biomarkers for predicting responsiveness to FGF-18 compound
MERCK PATENT GMBH0 citations60
US12332251B2Jun 17, 2025
Metabolic biomarkers for predicting responsiveness to FGF-18 compound
MERCK PATENT GMBH0 citations60
US12209136B2Jan 28, 2025
ADAMTS binding immunoglobulins
MERCK PATENT GMBH0 citations60
US9839665B2Dec 12, 2017
Aminostatin derivatives for the treatment of arthrosis
MERCK PATENT GMBH0 citations51
US12383603B2Aug 12, 2025
Markers useful in enrichment strategies for the treatment of osteoarthritis
MERCK PATENT GMBH0 citations50
US9750784B2Sep 5, 2017
Intraarticular application of pepstatin in the case of arthrosis
MERCK PATENT GMBH0 citations45